MX2015008333A - Metodos y composiciones para la administracion de oxibutinina. - Google Patents
Metodos y composiciones para la administracion de oxibutinina.Info
- Publication number
- MX2015008333A MX2015008333A MX2015008333A MX2015008333A MX2015008333A MX 2015008333 A MX2015008333 A MX 2015008333A MX 2015008333 A MX2015008333 A MX 2015008333A MX 2015008333 A MX2015008333 A MX 2015008333A MX 2015008333 A MX2015008333 A MX 2015008333A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- oxybutynin
- agents
- compositions
- methods
- Prior art date
Links
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005434 oxybutynin Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000003246 corticosteroid Substances 0.000 abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 2
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000000168 bronchodilator agent Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 239000012313 reversal agent Substances 0.000 abstract 1
- 229950000339 xinafoate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se dirige a métodos y composiciones para tratar enfermedades pulmonares que comprende administrar directamente a los pulmones de los pacientes una cantidad efectiva terapéuticamente de oxibutinina en combinación con uno o más agentes efectivos farmacéuticamente. La oxibutinina puede ser seleccionada del grupo que consiste de, pero no se limita a, una sal de xinafoato, una sal de palmitato, una sal pamoica, una sal de resonato, una sal de laureato y otras sales. Los agentes efectivos farmacéuticamente comprenden broncodilatadores, antinflamatorios, corticosteroides, agentes de inversión de corticosteroides o agentes de crecimiento alveolar, u otros agentes seleccionados de entre inhibidores de proteinasa o proteasa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/728,706 US9119777B2 (en) | 2008-05-30 | 2012-12-27 | Methods and compositions for administration of oxybutynin |
| PCT/US2013/074759 WO2014105446A1 (en) | 2012-12-27 | 2013-12-12 | Methods and compositions for administration of oxybutynin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015008333A true MX2015008333A (es) | 2015-11-09 |
Family
ID=51021931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008333A MX2015008333A (es) | 2012-12-27 | 2013-12-12 | Metodos y composiciones para la administracion de oxibutinina. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2938329A4 (es) |
| JP (1) | JP2016504358A (es) |
| KR (1) | KR20150100902A (es) |
| CN (1) | CN104955444A (es) |
| AR (1) | AR094287A1 (es) |
| AU (1) | AU2013368298B2 (es) |
| BR (1) | BR112015015421A2 (es) |
| CA (1) | CA2895955A1 (es) |
| EA (1) | EA201591218A1 (es) |
| HK (2) | HK1215396A1 (es) |
| IL (1) | IL239623A0 (es) |
| MX (1) | MX2015008333A (es) |
| NZ (1) | NZ628479A (es) |
| UY (1) | UY35230A (es) |
| WO (1) | WO2014105446A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3421049B1 (en) * | 2016-02-25 | 2020-07-29 | Hisamitsu Pharmaceutical Co., Inc. | Liquid external preparation |
| CN115667205A (zh) | 2020-05-05 | 2023-01-31 | 爱普宁公司(特拉华) | (r)-盐酸奥昔布宁的多晶形物形式 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1191930A2 (en) * | 1999-05-20 | 2002-04-03 | Sepracor Inc. | Methods for treatment of asthma using s-oxybutynin |
| US6339107B1 (en) * | 2000-08-02 | 2002-01-15 | Syntex (U.S.A.) Llc | Methods for treatment of Emphysema using 13-cis retinoic acid |
| MXPA05004584A (es) * | 2002-10-29 | 2005-07-26 | Pharmacia & Up John Company Ll | Compuestos de amonio cuaternario. |
| GB0410398D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| MX2007004976A (es) * | 2004-10-25 | 2007-06-14 | Schering Corp | Antagonistas de receptor m1 y/o m3 en combinacion con otros compuestos activos para tratar trastornos respiratorios. |
| US8415390B2 (en) * | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| US20090215734A1 (en) * | 2008-02-26 | 2009-08-27 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| CN102448309A (zh) * | 2009-06-16 | 2012-05-09 | 谭文 | 左旋(r)班布特罗在制备治疗呼吸性疾病的吸入性药物制剂和药物组合中的应用 |
| GB0918450D0 (en) * | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
| WO2011120779A1 (en) * | 2010-04-01 | 2011-10-06 | Chiesi Farmaceutici S.P.A. | Process for preparing carrier particles for dry powders for inhalation |
| CA2812952A1 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
-
2013
- 2013-12-12 CN CN201380068230.5A patent/CN104955444A/zh active Pending
- 2013-12-12 EA EA201591218A patent/EA201591218A1/ru unknown
- 2013-12-12 KR KR1020157020335A patent/KR20150100902A/ko not_active Ceased
- 2013-12-12 CA CA2895955A patent/CA2895955A1/en not_active Abandoned
- 2013-12-12 NZ NZ628479A patent/NZ628479A/en not_active IP Right Cessation
- 2013-12-12 WO PCT/US2013/074759 patent/WO2014105446A1/en not_active Ceased
- 2013-12-12 JP JP2015550444A patent/JP2016504358A/ja active Pending
- 2013-12-12 AU AU2013368298A patent/AU2013368298B2/en not_active Ceased
- 2013-12-12 BR BR112015015421A patent/BR112015015421A2/pt not_active IP Right Cessation
- 2013-12-12 HK HK16103431.3A patent/HK1215396A1/zh unknown
- 2013-12-12 MX MX2015008333A patent/MX2015008333A/es unknown
- 2013-12-12 HK HK16104715.8A patent/HK1216843A1/zh unknown
- 2013-12-12 EP EP13867956.8A patent/EP2938329A4/en not_active Withdrawn
- 2013-12-20 UY UY0001035230A patent/UY35230A/es not_active Application Discontinuation
- 2013-12-27 AR ARP130105037A patent/AR094287A1/es unknown
-
2015
- 2015-06-24 IL IL239623A patent/IL239623A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR094287A1 (es) | 2015-07-22 |
| UY35230A (es) | 2015-01-30 |
| JP2016504358A (ja) | 2016-02-12 |
| CA2895955A1 (en) | 2014-07-03 |
| EP2938329A4 (en) | 2016-08-10 |
| WO2014105446A1 (en) | 2014-07-03 |
| NZ628479A (en) | 2016-06-24 |
| KR20150100902A (ko) | 2015-09-02 |
| HK1215396A1 (zh) | 2016-08-26 |
| AU2013368298A1 (en) | 2015-07-02 |
| AU2013368298B2 (en) | 2016-08-11 |
| EA201591218A1 (ru) | 2015-11-30 |
| BR112015015421A2 (pt) | 2017-07-11 |
| EP2938329A1 (en) | 2015-11-04 |
| CN104955444A (zh) | 2015-09-30 |
| HK1216843A1 (zh) | 2016-12-09 |
| IL239623A0 (en) | 2015-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX369385B (es) | Productos para cicatrizar heridas tisulares. | |
| HK1215934A1 (zh) | 肽治疗剂及其使用方法 | |
| WO2016004093A3 (en) | Therapeutic compositions including galectin-3 inhibitors and uses thereof | |
| HK1204988A1 (en) | Methods and compositions for preventing or treating ophthalmic conditions | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| MX355742B (es) | Análogos deuterados del ácido 4-hidroxibutírico. | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2013520405A5 (es) | ||
| UA113165C2 (xx) | Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат | |
| BR112013029246A2 (pt) | 4-amino-5-flúor-3-[6- (4-metilpiperazin- 1 - il) - 1h - benzimidazol - 2 - il] - 1h - quinolin-2-ona para uso no tratamento de carcinoma adenoide cístico | |
| MY170802A (en) | Treatment of pulmonary disease | |
| WO2014099226A3 (en) | Personal cleansing compositions containing zinc amino acid/trimethylglycine halide | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| SG10201909122QA (en) | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| WO2012092458A3 (en) | Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof | |
| NZ609719A (en) | Pharmaceutical composition | |
| PH12013501855A1 (en) | Combination therapies for hematologic malignancies | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| TN2014000031A1 (en) | Use of organic compound for the treatment of noonan syndrome | |
| WO2013117503A3 (en) | Pi3k inhibitors for treating fibrotic diseases | |
| TW201129361A (en) | Methods for treating pain | |
| MX2015008333A (es) | Metodos y composiciones para la administracion de oxibutinina. | |
| MX336278B (es) | Composiciones y metodos para la prevencion y el tratamiento de heridas. |